PTPRZ1 is, if at all, barely expressed across adult tissues24, and the TCR was isolated from a vaccinated patient without notable adverse events23; hence, we hypothesized that the TCR had undergone thymic selection, making both off-target and on-target off-tumor toxicities unlikely. The gene discussed is PTPRZ1; the disease is neoplasm.